Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data
Statistics in Medicine · 30.11.2024 · 43 (27) · 5182-5192
DOI: 10.1002/sim.10230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 07.10.2024. Verfasst von Jin Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Heal…. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Chlamydia Infections, Computer Simulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Intramural NIH HHS.
Abstract (Originalsprache)
We consider the problem of combining multiple biomarkers to improve the diagnostic accuracy of detecting a disease when only group‐tested data on the disease status are available. There are several challenges in addressing this problem, including unavailable individual disease statuses, differential misclassification depending on group size and number of diseased individuals in the group, and extensive computation due to a large number of possible combinations of multiple biomarkers. To tackle these issues, we propose a pairwise model fitting approach to estimating the distribution of the optimal linear combination of biomarkers and its diagnostic accuracy under the assumption of a multivariate normal distribution. The approach is evaluated in simulation studies and applied to data on chlamydia detection and COVID‐19 diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
- Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
- Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Jin Yang, Wei Zhang, Paul S Albert, Aiyi Liu, Zhen Chen
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Intramural NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Yang, J., Zhang, W., Albert, P. S., Liu, A., & Chen, Z. (2024). Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data. Statistics in Medicine, 43(27), 5182-5192. https://doi.org/10.1002/sim.10230
Vancouver
Yang J, Zhang W, Albert PS, Liu A, Chen Z. Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data. Statistics in Medicine. 2024;43(27):5182-5192. doi:10.1002/sim.10230
BibTeX
@article{Yang2024,
author = {Yang, Jin and Zhang, Wei and Albert, Paul S and Liu, Aiyi and Chen, Zhen},
title = {Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data},
journal = {Statistics in Medicine},
year = {2024},
volume = {43},
number = {27},
pages = {5182--5192},
doi = {10.1002/sim.10230}
}
EUVIMED